An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
The UK has seen a surge in the number of type 2 diabetes cases, with data analysis from Diabetes UK showing that one in five ...
Glomerular hyperfiltration may increase CVD risks, including myocardial infarction and heart failure, for patients with type ...
Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...
Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...
Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.
News Medical on MSN7d
Type 1 diabetes patients face lower cardiovascular risk than Type 2 diabetesA new study published in JSCAI has revealed a lower risk of cardiovascular events for patients with Type 1 diabetes (often ...
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
Consultant in endocrinology and diabetes Professor Vinod Patel discusses current recommended pharmacological treatment ...
Researchers at the University of Michigan have identified how mitochondrial dysfunction impairs insulin-producing pancreatic ...
Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.Across the 68 markets, sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback